BZBaha Zantour

Baha Zantour

*This is an algorithmically generated author record based on publicly available information.

Baha Zantour has a total of 129 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Impact on quality of life and sleep of hydrocortisone hormone replacement in adrenal insufficiency.

    by Ines Charrada, Alaya Wafa, Boubaker Fadia, Houcem Mrabet, Zantour Baha, Berrich Olfa, Sfar Mohamed Habib

    Introduction: Hydrocortisone (HC) is the most widely used replacement molecule in the treatment of adrenal insufficiency (AI). This substitution treatment is far from ideal especially as it is impossible to reproduce the nycthemeral cycle of cortisol with its current galenic form which has a short half-life. The aim of our work was to determine the impact of HC treatment of peripheral AI on the long-term quality of life and sleep. Patients and methods: This is a descriptive and analytical study involving 77 patients with peripheral AI (66 women and 11 men), all treated with HC. For each patient, we determined the duration of the disease, the daily and cumulative dose of HC, the number of times HC was taken, the SF-36 quality of life score and the Pittsburgh sleep quality score in 58 patients. Results: The mean age was 40.5 years (range: 22–63 years). The mean duration of progression was 7.7 years. We found that the percentage of patients with impaired quality of life was higher than in the healthy Tunisian adult population (79.31% vs. 51%), with a lower mean SF-36 global score (54.9 vs. 69.4). We noted a better quality of life in case of three HC intakes compared to two (P: 0.006). Regarding sleep quality, we found that 24% of patients had a sleep disorder of the type insomnia of the second part of the night with early awakening, without any correlation with the HC dose. This prevalence was higher than in the general adult population (24% vs. 9.7%). This quality of sleep seems to be better in case of three intakes of HC (morning, noon and afternoon). Conclusion: Our results agree with those of the literature, since it appears that a 3-dose schedule was more beneficial for quality of life and long-term sleep. However, even with these HC dosing regimens, we remain far from the physiological rhythm of cortisol, and new modified-release HC preparations (DuoCort/Chronocort) could allow to better mimic the nycthemeral cycle of cortisol in patients suffering from AI.


  • Une hyperprolactinémie transitoire après prise de sulpiride révélant un macro adénome hypophysaire non sécrétant chez une jeune patiente

    by S. Trigui, F. Boubaker, A. Belkacem, R. Ajili, H.E.O. Mrabet, N. Lassoued, B. Zantour, W. Alaya, M.H. Sfar


  • Open Access

    Risk assessment for foot ulcers among Tunisian subjects with diabetes: a cross sectional outpatient study

    by B. Zantour, S. Bouchareb, Z. El Ati, F. Boubaker, W. Alaya, W. Kossomtini, M. H. Sfar

    Background: Diabetic foot is an underestimated and redoubtable diabetes complication. The aims of our study were to assess diabetic foot ulcer risk factors according to International Working Group on the Diabetic Foot (IWGDF) classification, stratify patients into risk categories and identify factors associated with higher-risk grade.Methods: Cross-sectional setting over a period of 07 months, patients were randomly selected from the diabetic outpatients attending our unit of diabetology. Questionnaire and clinical examination were made by the same physician. Patients free of active foot ulcer were included.Results: Among 230 patients evaluated, 10 had an active foot ulcer and were excluded. Five patients (2.27%) had a history of foot ulcer and 3(1.36%) had a lower-limb amputation. Sensory neuropathy, as measured by the 5.07(10 g) Semmes-Weinstein monofilament testing, was present in 23.63% of patients, whereas 36.82% had a peripheral arterial disease based on clinical findings, and 43.63% had foot deformities. According to the IWGDF classification, Group 0: 72.72%, Group 1: 5.9%, Group 2: 17.73% and Group 3: 3.63%. After univariate analysis, patients in higher–risk groups were significantly more often female, had higher age and BMI, longer diabetes duration, elevated waist circumference, low school level, retinopathy and hyperkeratosis. Multivariate logistic regression analysis identified 3 significant independent factors associated with high-risk groups: retinopathy (OR = 2.529, CI95 [1.131–5.655],p = 0.024), hyperkeratosis (OR = 2.658, CI95 [1.222–5.783],p = 0.014) and school level (OR = 0.489, CI95 [0.253–9.44],p = 0.033).Conclusions: Risk factors for foot ulceration were rather common in outpatients with diabetes. The screening of patients at risk for foot ulceration should start early, integrated with sustainable patient education.


  • Open Access

    Risk assessment for foot ulcers among Tunisian subjects with diabetes: a cross sectional outpatient study

    by Baha Zantour, Soumaya Bouchareb, Zohra El Ati, Fadia Boubaker, Wafa Alaya, Wassiaa Kossomtini, Mmohamed Habib Sfar

    BackgroundDiabetic foot is an underestimated and redoubtable diabetes complication. The aims of our study were to assess diabetic foot ulcer risk factors according to International Working Group on the Diabetic Foot (IWGDF) classification, stratify patients into risk categories and identify factors associated with higher-risk gradeMethodsCross-sectional setting over a period of 07 months, patients were randomly selected from the diabetic outpatients attending our unit of diabetology. Questionnaire and clinical examination were made by the same physician. Patients free of active foot ulcer were included. ResultsAmong 230 patients evaluated, 10 had an active foot ulcer and were excluded. Five patients (2.27%) had a history of foot ulcer and 3(1.36%) had a lower-limb amputation. Sensory neuropathy, as measured by the 5.07(10g) Semmes-Weinstein monofilament testing, was present in 23.63% of patients, whereas 36.82% had a peripheral arterial disease based on clinical findings, and 43.63% had foot deformities. According to the IWGDF classification, Group 0: 72.72%, Group 1: 5.9%, Group 2: 17.73% and Group 3: 3.63%. After univariate analysis, patients in higher–risk groups were significantly more often female, had higher age and BMI, longer diabetes duration, elevated waist circumference, low school level, retinopathy and hyperkeratosis. Multivariate logistic regression analysis identified 3 significant independent factors associated with high-risk groups: retinopathy (OR=2.529, CI95 [1.131-5.655], p=0.024), hyperkeratosis (OR=2.658, CI95 [1.222-5.783], p=0.014) and school level (OR=0.489, CI95 [0.253-9.44], p=0.033)Conclusions Risk factors for foot ulceration were rather common in diabetic outpatients. The screening of diabetic patients at risk for foot ulceration should start early, integrated with sustainable patient education

  • Open Access

    Pituitary Apoplexy

    by Manel Jemel, Wafa Alaya, Fedia Boubaker, Olfa Berrich, Baha Zantour

    Pituitary apoplexy is a rare clinical emergency due to acute ischemic infarction or hemorrhage of the pituitary gland. As this disorder most often involves a pituitary adenoma, especially nonfunctioning tumors, the syndrome should be referred to as pituitary tumor apoplexy. The precise physiopathology is not completely clear. Although in most cases it occurs spontaneously, pituitary apoplexy can be precipitated by many risk factors. The main symptom is headache of sudden onset associated with visual disturbances, signs of meningeal irritation, and/or endocrine dysfunction. Corticotropic deficiency is a potentially life-threatening disorder. Magnetic resonance imaging is the most sensitive to confirm the diagnosis by revealing a pituitary tumor with hemorrhagic and/or necrotic components. Earlier studies used to consider urgent decompression of the lesion surgically, but nowadays, more recent studies favor conservative management in selected patients (those without important visual acuity or field defects and with normal consciousness). This wait-and-see approach gives evidence of excellent outcomes in terms of oculomotor palsy, pituitary function, and subsequent tumor growth. Surgical decompression may be necessary in some cases. Once the acute phase is over, the patient should be reevaluated for hormonal deficiencies. Moreover, spontaneous remission of syndromes, such as acromegaly, may be caused by pituitary adenoma apoplexy.

  • Open Access

    The cortical carcinoma: a rare cause of primary hyperaldosteronism

    by Baha Zantour, Ines Charrada, Zohra Elati, Fatma Larbi Ammari, Fadia Boubaker, Sondes Arfa, Olfa Berriche, Wafa Alaya, Mohamed Habib Sfar

    Corticosurrenaloma is a rare malignant tumor of the adrenal gland that often secretes corticosteroids, sex steroids and precursors. Aldosterone-producing corticosurrenaloma is very rare, accounting for 1 case/10million inhabitants. We report the case of a 38-year old man presenting with severe arterial hypertension associated with deep hypokalaemia (2.2 mmol/L). Exploration showed primary hyperaldosteronism (aldosterone = 2645 pmol/l, aldosterone/renin ratio = 327 pmol/MUI), with hypersecretion of glucocorticoids. Abdominopelvic CT scan revealed left poorly differentiated and heterogeneous adrenal mass measuring 9cm, infiltrating into the surrounding adipose tissue and the diaphragm, extending into the left renal vein, with regional adenopathy and hepatic nodule measuring 4cm. The patient underwent radical nephrectomy followed by right hepatectomy two months after resulting in remission. A year after the patient developed lung metastases. This study highlights that corticosurrenaloma should be suspected in patients with primary aldosteronism despite its rarity


  • Maladie de Behçet et hyperparathyroïdie : association fortuite ?

    by S. Arfa, M. Thabet, H. Nouira, F. Boubaker, B. Zantour, O. Berriche, M.H. Sfar

  • Le phéochromocytome : étude 10 cas

    by B. Zantour, S. Tahri, F. Boubaker, Z. Elati, I. Charrada, H. Mrabet, O. Berriche, W. Alaya, M.H. Sfar

  • Association dysthyroïdie périphérique et maladies auto-immunes : à propos de dix cas

    by S. Arfa, H. Nouira, M. Thabet, F. Boubaker, B. Zantour, O. Berriche, M.H. Sfar

  • Caractéristiques cliniques et paracliniques de la maladie de Cushing : à propos de 12 cas

    by W. Alaya, W. Ben Othman, F. Boubaker, I. Charrada, O. Berriche, B. Zantour, M. Sfar